Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: A10AE07

Awiqli(insulin icodec)

Diabetes Mellitus;Diabetes Mellitus, Type 2

Marketing Authorisation Holder: Novo Nordisk A/S

EMA Authorisation: 17/05/2024

INN: insulin icodec

Indication

Treatment of diabetes mellitus in adults

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Awiqli — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.